SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses the implications of the company's recent Phase III trial failure for its Alzheimer's drug, with some investors expressing disappointment while others see it as an opportunity to buy. Despite the setback, there is optimism surrounding Novo Nordisk's position in the weight loss market, particularly with the potential upcoming approval of its oral Wegovy pill and comparison of CagriSema vs Zepbound study results.

Pony.ai, Inc. develops artificial intelligence-based robot designed for autonomous driving. The firm's software algorithms and infrastructure enables a vehicle to perceive its surroundings, predict what others will do, and maneuver itself accordingly. The company was founded by Jun Peng and Tian Cheng Lou in November 4, 2016 and is headquartered in Guangzhou, China.

Pony AI Inc. - ADR

Pony AI Inc

Pony AI is trending due to news of expanded robotaxi operations and partnerships, including a recent permit in Shanghai. The community is weighing the company's growth prospects against its financial performance, especially regarding profitability targets. Broader discussions involve comparing Pony AI to competitors in the autonomous driving space and assessing the impact of these developments on its market position.

Diginex Ltd. (Hong Kong) is a blockchain financial services and technology company. Its products include diginexESG, diginexLUMEN, diginexAPPRISE, diginexLUMEN Pro, and CSRD framework. The company was founded by Miles Christian Pelham on May 15, 2020 and is headquartered in London, the United Kingdom.

Diginex Ltd.

DGNX is trending due to its recent acquisition of The Remedy Project, sparking discussions about the company's expansion into human-rights remediation. The community is also actively analyzing potential trading strategies based on historical patterns of similar stocks. Options traders are closely monitoring put contracts, anticipating potential downside amidst the volatility.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending due to strong Q3 2025 earnings, highlighted by a 144.3% YoY revenue increase and significant growth in robotaxi revenue, with community members noting global expansion and regulatory milestones in the UAE and Switzerland. Investors are focused on WeRide's progress toward deploying hundreds of thousands of robotaxis by 2030 and its partnerships with companies like Bosch, Uber, and Grab. The conversation also includes comparisons to competitor Pony.ai, whose stock performance and institutional ownership are being weighed against WeRide's recent gains and expansion efforts.

Monad

Monad is trending as users discuss its upcoming launch and token distribution, particularly excitement around receiving tokens from the Coinbase presale. The community is actively speculating on potential price movements and strategies, with some comparing it to other recent launches. There's also discussion around the mainnet launch date.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending amid mixed sentiment, as discussions range from its ties to controversial figures to its evolving stance on cryptocurrency and potential competition with Bitcoin. The community is actively debating JPMorgan's investment strategies, alleged market manipulation, and the implications of its exploration of blockchain technology and stablecoins. Additionally, some traders are monitoring technical indicators to predict JPM's short-term price movements, while others are discussing potential investigations and regulatory scrutiny.

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Alvotech

Alvotech ($ALVO) is trending following the announcement of European approval for AVT03, a biosimilar to Prolia and Xgeva, used in bone disease treatment, sparking bullish sentiment. Despite some community concerns about cash flow and previous manufacturing setbacks, the biosimilar's approval and analyst upgrades are fueling optimism. Discussions center on the company's potential in the biosimilar market and strategic partnerships.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending as the stock price rises following news of its AI integration with Open AI, which is expected to enhance merchant and customer experiences, with some analysts predicting a significant price target increase. However, some community members are skeptical about the sustainability of Shopify's growth, citing competition and valuation concerns, while others point to the company's strong position in the e-commerce sector and potential for further gains.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi-Aventis ($SNY) is trending amid speculation surrounding potential acquisitions, particularly in the MASH and obesity spaces, with $ALT, $GUTS, and $IVA being mentioned as possible targets. Community discussions revolve around the company's pipeline expansion needs and potential partnerships, with some users highlighting data integrity concerns around one of the speculated targets. The broader context involves Sanofi's strategic moves to strengthen its immunology and vaccine portfolio.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

MFI is trending due to its recent $500M private placement aimed at building a Bitcoin Cash treasury, fueling speculation about a potential pivot into crypto equity. Community members are discussing the involvement of a Chinese billionaire and the possibility of MFI becoming a major player in the crypto space. The stock's volatile price action and small float are contributing to the heightened interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul><li>Palantir CEO Alex Karp identified two AI markets - broad basic-use AI and a results-driven subset.</li><li>He said the subset capable of changing revenue, margins, or operational outcomes is Palantir’s focus.</li><li>He also warned that other countries cannot easily replicate U.S. advantages across the technology stack.</li></ul>Palantir (PLTR) CEO Alex Karp reportedly said on Thursday that while the overall AI market is large, only a fraction&nbsp;of it produces meaningful results, capable of driving revenue or margin improvements.&nbsp;“There are really two AI markets,” Karp said during an&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/video/palantir-downstream-americas-success-ceo-143534800.html">interview</a> at Yahoo Finance Invest. “From Palantir's perspective, people using AI call it enhanced intelligence to do basic things, but things that are not sophisticated enough so that they would change your revenue or margins – that is a very large market.”<a href="http://stocktwits.com/symbol/PLTR">PLTR’s stock</a> fell 1.2% in pre-market trade amid broader weakness in the market. On Stocktwits, retail sentiment around the company remained in ‘bullish’ territory over the past day.&nbsp;<h2 class="st-heading-2">Two AI Markets –&nbsp; Hype Vs. Impact</h2>Karp differentiated between the “enhanced intelligence” applications that are widely discussed but often fail to move the needle, and the subset of AI that produces quantifiable results.&nbsp;“The part of the market that is weak… is in the institutional context,” he said. “The part of the market we’re in—where we can show results quickly and get paid—is expanding, and that part will dominate the rest of the institutional market.”According to him, this results-driven segment can rapidly influence business performance or battlefield outcomes, allowing organizations to capture value without restructuring or isolating operations for years.“While most developers are focused on supporting basic AI models, we intend to lead in applications that deliver measurable impact quickly,” Karp said. “The subset of the market we target is expanding and will dominate institutional AI adoption.”<h2 class="st-heading-2">Economic Strength Tied To National Security</h2>Karp also tied AI adoption to broader U.S. economic and strategic strength. He emphasized that America is uniquely positioned with dominance across the technology stack, which allows the country to leverage AI both commercially and militarily.“The ability to defend ourselves and grow our economy is tied to the same resources,” Karp said. “Our challenge is to grow GDP in a way that positively affects skilled workers—welders, truck drivers, engineers—while maintaining technological leadership globally.”He also warned that replicating the U.S. advantage would be difficult for other countries due to the country’s unique concentration of resources and talent. “Europe, for example, does not control any part of the stack as a dominant player,” Karp said. “Our role is to leverage what we have, not squander it.”Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/circle-stock-gains-after-jpmorgan-turns-bullish-cathie-woods-ark-invest-buys-the-dip/cLP9RYgRE3X">Circle Stock Gains Pre-Market After JPMorgan Turns Bullish, Cathie Wood’s Ark Invest Buys The Dip</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Alex Karp, CEO of Palantir Technologies, talks to members of the media at the Allen & Company Sun Valley Conference on July 10, 2025 in Sun Valley, Idaho. (Photo by Kevin Dietsch/Getty Images)

Palantir CEO Alex Karp Says There Are Two AI Markets And Only One ‘Actually Works’: Report 

Speaking at Yahoo Finance Invest, Karp said consumer-oriented AI may create hype without tangible benefits.

Equity

Kerrisdale Capital on Wednesday disclosed a short position on Tom Lee-led Bitmine Immersion Technologies (BMNR), stating that the digital asset treasury (DAT) playbook has become “basic and unoriginal.”<a href="http://stocktwits.com/symbol/BMNR">BMNR’s stock</a> continued to gain in morning trade, up 1.5%. Retail sentiment on Stocktwits, however, dipped to ‘neutral’ from ‘bullish’ over the past day.The equities market has seen a surge in companies pivoting to holding cryptocurrencies on their balance sheets as the Trump administration took a friendlier stance on regulation. “As near-idential copycats overwhelm the market, premiums are collapsing and the ability to issue shares well above NAV to boost&nbsp;ETH-per-share is disappearing,” the research firm said.Kerrisdale Capital pointed to Michael Saylor-backed Strategy (MSTR) as an example of reducing net asset value (NAV). “The OG DAT, MSTR, has seen its premium slide from 2-2.5x NAV to around 1.4x after unpopular financings &amp; policy reversals broke the spell,” it said. “If the pioneer with a cult following can’t keep the magic alive, no one can.”It added that BMNR’s&nbsp;premium has also been sliding lower, and will probably “continue bleeding” until it reaches or falls below the NAV. “The lower it goes, the slower the ETH-per-share accretion, until it collapses below 1,” the firm said.BMNR is currently the largest Ethereum holding DAT in the market with more than&nbsp;two million tokens in its treasury, followed by SharpLink (SBET),&nbsp;which has around 800 million tokens. According CoinGecko data, there are around 13 companies with Ethereum on their balance sheets. This includes companies like Fundamental Global (FGNX) and BitDigital (BTBT),&nbsp;which also announced the&nbsp;inclusion of&nbsp;Ethereum as a part of their long-term treasury strategy this year.In addition to reducing returns, Kerrisdale Capital also critiqued Lee’s leadership. “Tom Lee has proven to be an underwhelming meme lord. No cat videos. No speeches to mortgage your house to buy ETH,” it said. “Poor utilization of caps lock, emojis, GIFs, AI slop. Too TradFi and boring, Lee pales in comparison to Saylor and Chamath [Palihapitiya].”The firm clarified that it’s not short on Ethereum but&nbsp;that it is skeptical of BMNR because the company’s “whole pitch is to get investors to overpay for copying a playbook that no longer works.”&nbsp;<a href="http://stocktwits.com/symbol/ETH.X">Ethereum’s price</a> was trading at around $4,500 in early morning trade after more than 4% in the last 24 hours.Meanwhile, Consensys co-founder Joseph Lubin reportedly said that Ethereum (ETH)-holding digital asset treasury (DAT) companies could evolve into the “Berkshire Hathaway” as the financial landscape shifts.“The real opportunity is to be the Berkshire Hathaway of the next global economy, the more decentralized global economy,” he&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://cointelegraph.com/news/ethereum-dats-the-next-berkshire-hathaway-consensys-founder">told</a> CoinTelegraph on sidelines of Token2049 in Singapore. Lubin is the also the chairman of SharpLInk Gaming.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bnb-hits-record-1-330-while-btc-eth-retreat-amid-650-million-liquidations/ch6E0XTR3i3">BNB Hits Record $1,330 While Bitcoin, Ethereum Retreat Amid $650 Million Liquidations</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

FundStrat Global Advisors Managing Partner Tom Lee speaks onstage at Yahoo Finance All Markets Summit on October 25, 2017 in New York City. (Photo by Cindy Ord/Getty Images for Yahoo)

Kerrisdale Capital Shorts Bitmine, Calls Ethereum Treasury Strategy ‘Basic And Unoriginal’

The research firm also critiqued Tom Lee’s leadership, stating that he has “proven to be an underwhelming meme lord.”

Galaxy Digital (GLXY) announced on Monday the launch of GalaxyOne, a consumer-focused platform and app that integrates a 4% cash account, crypto custody and trading, and zero-commission trading in U.S. equities and ETFs.<a href="https://stocktwits.com/symbol/GLXY">Galaxy Digital’s stock</a> surged more than 10% in pre-market trading,&nbsp;putting it on track to reach its highest level since October 2008.U.S. users who meet know-your-customer (KYC) requirements can immediately buy, hold, and transfer Bitcoin (BTC), Ethereum (ETH), Solana (SOL), and Paxos Gold (PAXG). The mobile app, available on both Android and iOS, also supports trading in more than 2,000 U.S. stocks and ETFs, including fractional shares, with no commission fees.&nbsp;With the launch of its new product, Galaxy will now compete against the likes of Robinhood (HOOD) and eToro (ETOR) in the retail space, who also offer both cryptocurrency and equities trading.CEO Mike Novogratz said the launch aligns with Galaxy’s strategy to become a “full spectrum financial services provider,” delivering regulated and accessible products across all market segments.GalaxyOne was developed following Galaxy’s acquisition of the retail-focused financial app Fierce last year. Galaxy reported spending $12.5 million on the acquisition in its fourth-quarter (Q4) filing with the Securities and Exchange Commission (SEC).Galaxy Digital’s stock has doubled in value this year and gained more than 185% in the last 12 months.&nbsp; Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bnb-hits-all-time-high-leads-altcoin-rally-after-bitcoin-s-weekend-surge-lifts-crypto-market-to-record/ch6RTHzR3gR">BNB Hits All-Time High, Leads Altcoin Rally After Bitcoin’s Weekend Surge Lifts Crypto Market To Record</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mike Novogratz, CEO of Galaxy Digital, gestures as he speaks during the Bitcoin 2022 Conference at Miami Beach Convention Center on April 8, 2022 in Miami, Florida. (Photo by Marco Bello/Getty Images)

Galaxy Digital Stock On Track To Hit October 2008 Highs After GalaxyOne Launch

With the launch of its new product, Galaxy will now be competing against the likes of Robinhood and eToro.

Jumia Technologies AG (JMIA) received a major upgrade from RBC Capital Markets after meetings with company leadership, which boosted confidence in its outlook.&nbsp;RBC upgraded the stock to ‘Outperform’ from ‘Sector Perform’ and lifted the price target to $15 from $6.50, citing improved supply conditions and weakening currency pressures as key positives, according to Thefly.&nbsp;&nbsp;<a href="https://stocktwits.com/symbol/JMIA">Jumia Technologies' stock</a> traded over 21% higher by Tuesday afternoon. On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume improved to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:932/111;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_16_133025_png_6fd5fb61a1.webp" alt="JMIA’s Sentiment Meter and Message Volume as of 01:15 p.m. ET on Sep. 16, 2025 | Source: Stocktwits" width="932" height="111"><figcaption>JMIA’s Sentiment Meter and Message Volume as of 01:15 p.m. ET on Sep. 16, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 775% increase in user message count&nbsp;over 24 hours, as of Tuesday morning.&nbsp;A Stocktwits user commended the stock’s gain since June.&nbsp;<stembedurl>https://stocktwits.com/stock_head/message/628849884</stembedurl>RBC’s bullish stance follows virtual meetings with Jumia’s CEO and CFO, where management appeared “incrementally positive” about the company’s ability to benefit from easing foreign exchange headwinds.&nbsp;The firm believes there’s room for upside as Jumia scales its operations with supply expansion and a boost in order growth.&nbsp;RBC expects Jumia to strengthen its relationships and gain momentum with Chinese suppliers.Jumia is one of Africa’s top e-commerce platforms. It runs its own delivery network, called Jumia Logistics, and offers digital payments through JumiaPay.&nbsp;The company’s second-quarter (Q2) revenue of $45.6 million exceeded the analyst consensus estimate of $44.8 million, according to Fiscal AI data. The Gross Merchandise Value (GMV) for Q2 rose 6% year-over-year to $180.2 million.&nbsp;Jumia Technologies’ stock has gained over 213% year-to-date and over 161% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/turbo-energy-stock-shots-up-over-460-percent-to-hit-a-record-high-today/chwyFY3Rdzq">Turbo Energy Stock Shoots Up Over 460% To Hit A Record High Today – Find Out More</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Jumia Technologies will be issuing over 20.22 million American Depositary Shares turning Wall Street against it.

Jumia Technologies Stock Jumped 21% Today After A Major Wall Street Upgrade – Check Out The New Price Target

RBC upgraded the stock to ‘Outperform’ from ‘Sector Perform’ and lifted the price target to $15 from $6.50, citing improved supply conditions and weakening currency pressures.

Rocket Lab (RKLB) experienced a more than 700% increase in retail user message count on Stocktwits over the last 24 hours as of Wednesday morning, and was the top-trending stock on the platform.Retail sentiment on <a href="https://stocktwits.com/symbol/RKLB">Rocket Lab</a> improved to ‘extremely bullish’ from ‘bullish’ territory a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.<figure class="image"><img style="aspect-ratio:796/107;" src="https://news.stocktwits-cdn.com/RKLB_sentiment_png_2310e5aede.webp" alt="RKLB sentiment.png" width="796" height="107"><figcaption>RKLB sentiment and message volume September 3, 2025, as of 1:10 pm ET | Source: Stocktwits</figcaption></figure>The stock's watchlist count on Stocktwits doubled to 43,281 in a year.Notably, the company's shares declined 10% by midday trading on Wednesday, despite no stock-specific news. The shares appear to have taken a breather following the massive rally seen over the last year. Rocket Lab shares have gained 75% this year and have jumped over 600% over the previous 12 months.Last week, Roth Capital also raised its price target on Rocket Lab to $60 from $50 and maintained a ‘Buy’ rating, according the TheFly. The firm noted that it was impressed by Rocket Lab's progress toward the initial Neutron launch.The Neutron support infrastructure and launch pad infrastructure are all in place for initial launch, Roth Capital said. Rocket Lab opened Launch Complex 3 on August 28, its dedicated test, launch, and landing facility for its reusable rocket, Neutron. The pad is located within the Virginia Spaceport Authority’s (VSA) Mid-Atlantic Regional Spaceport (MARS) at Pad 0D on Wallops Island, Virginia.The company stated that Launch Complex 3 is poised to deliver the largest orbital launch capacity in the Spaceport’s history with Neutron, which is capable of launching 13,000 kg to space for commercial constellations, national security, and interplanetary missions, as well as eventually supporting human spaceflight.In late August, Rocket Lab&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rklb-stock-lifts-off-10-after-70th-electron-launch/chssMD9RdSc">launched</a> its 70th Electron mission as part of its ‘Live, Laugh, Launch’ mission.&nbsp;The ‘Live, Laugh, Launch’ was Electron’s 12th mission of 2025 as Rocket Lab continues to execute an accelerated schedule of Electron launches.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/campbells-ceo-flags-consumer-caution-sees-surge-in-home-cooking/chwcc2mRdoR">Campbell’s CEO Flags Consumer Caution, Sees Surge In Home Cooking And Wellness Demand</a>

Rocket Lab’s 360% surge so far in 2024 has brought CEO Peter Beck’s 10% stake in the company to $970 million. | Source: Rocket Lab USA 

This Aerospace Stock Witnessed A 700% Explosion In Retail Chatter On Stocktwits – More Details Inside

Last week, Roth Capital raised its price target on Rocket Lab to $60 from $50 and noted that it was impressed by the company’s progress toward the initial Neutron launch.

Autonomous driving technology company Mobileye Global Inc. (MBLY) on Thursday increased its full-year revenue guidance and lowered its operating loss forecast, citing continued strength in supply-demand dynamics and increased demand for its autonomous driving chips.“Stronger visibility on industry supply-demand alignment since late-April supports our decision to raise the full-year outlook, while we continue to maintain a conservative stance given the broader macro environment,” <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.mobileye.com/news-releases/news-release-details/mobileye-releases-second-quarter-2025-results-updates-full-year">said</a> Mobileye President and CEO Amnon Shashua, while also predicting an “inflection” in the company’s growth trajectory in 2027.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MBLY">Mobileye</a> jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:623/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_24_at_8_53_36_AM_png_4bc34a33af.webp" alt="MBLY's Sentiment Meter and Message Volume as of 8:53 a.m. ET on July 24, 2025 | Source: Stocktwits" width="623" height="60"><figcaption>MBLY's Sentiment Meter and Message Volume as of 8:53 a.m. ET on July 24, 2025 | Source: Stocktwits</figcaption></figure> The company now expects revenue of $1.77 billion to $1.89 billion for the full year 2025, up from its previous guidance range of $1.69 billion to $1.81 billion.Operating loss is expected to be between $512 million and $436 million for the year, which is narrower than the company’s previous estimate of $574 million to $489 million in operating loss.The company stated that the new guidance includes its estimates of production impacts related to current tariffs imposed on complete vehicles imported into the United States, as well as tariffs on imported vehicle components used in U.S. vehicle production. However, the company said it assumes no further tariff developments or increases.For the second quarter, the company reported a 15% increase in revenue to $506 million, surpassing an analyst estimate of $495.91 million, according to data from Fiscal AI. The company attributed the rise in revenue to strong demand for its EyeQ System-on-Chip, a custom hardware and software solution designed explicitly for Advanced Driver Assistance Systems (ADAS) and self-driving systems.Adjusted earnings per share came in at $0.13, compared to $0.09 in the corresponding quarter of 2024, and above an expected $0.11.A Stocktwits user opined that the stock is still a “bit expensive” and added that they would like a cheaper entry point.<stembedurl>https://stocktwits.com/eskitrades/message/622241885</stembedurl>&nbsp;&nbsp;Mobileye had $1.7 billion of cash and cash equivalents and zero debt as of June 28, 2025.MBLY stock is down by 20% this year and by about 29% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-registrations-slump-in-europe-yet-again-in-june/ch8ywW1R5HO">Tesla Registrations Slump In Europe Yet Again In June: Retail Sentiment Slips Amid 289% Jump In Chatter</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Mobileye Global, Inc. logo appears on a smartphone screen in this illustration photo in Reno, United States, on December 23, 2024. (Photo by Jaque Silva/NurPhoto via Getty Images)

Mobileye CEO Sees Inflection In 2027 Growth Trajectory As Company Hikes Full-Year Revenue Outlook: Retail Thinks Stock Is Still A ‘Bit Expensive’

The company stated that the new guidance includes its estimates of production impacts related to current tariffs imposed on complete vehicles imported into the United States and tariffs on imported vehicle components used in U.S. vehicle production. 

Vertiv Holdings (VRT) surged more than 13% on Wednesday after the AI infrastructure firm raised its full-year guidance and signaled confidence in managing new tariffs under President Donald Trump’s trade policy.First-quarter (Q1) earnings came in at $0.64 per share, slightly above the $0.62 consensus estimate, according to Koyfin. Revenue for the quarter rose 24% year-over-year (YoY) to $2.04 billion, beating Wall Street’s $1.94 billion forecast. Organic net sales climbed 25%.The maker of power and cooling equipment for data centers said it now expects full-year 2025 revenue between $9.325 billion and $9.575 billion, up from its prior range of $9.125 billion to $9.275 billion.&nbsp;“We’re seeing accelerated scaling of AI deployments across the data center market,” said CEO Giordano Albertazzi. “Our partnership with Nvidia continues to place us at the heart of industrial-scale AI factory deployments.”He added that the updated forecast takes into account the anticipated impact of new U.S. tariffs, which have become a growing concern for manufacturers with global supply chains.“Although the tariff environment remains fluid, our goal is to significantly mitigate the effect of tariffs as we enter 2026,” he stated, adding that the company is working to mitigate the tariff impact through operational flexibility, a diversified manufacturing footprint, and commercial strategy shifts.The company said it continues to shift production to Mexico under the USMCA trade framework, and said only a single-digit percentage of its U.S. factory inputs currently come from China. Vertiv said it aims to have all U.S.-bound components manufactured in Mexico.Despite Wednesday’s rally,&nbsp;<a href="https://stocktwits.com/symbol/VRT">Vertiv’s stock</a> remains down more than 30% year-to-date, though it has held a 4% gain over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ge-vernova-cfo-sees-no-material-impact-from-trump-tariffs-on-outlook-q1-2025-earnings/chQmzXGRbgO">GE Vernova CFO Sees No ‘Material Impact’ From Trump Tariffs On Outlook – Stock Surges On Q1 2025 Earnings Beat</a>&nbsp;

In this photo illustration, the logo of Vertiv Holdings Co is displayed on a smartphone screen on April 20, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Vertiv Stock Surges On Q1 Beat, Improved 2025 Outlook — CEO Says Trump Tariff Impact Will Be Mitigated By 2026

The company now expects full-year 2025 revenue between $9.325 billion and $9.575 billion, up from its prior guidance of $9.125 billion to $9.275 billion. 

Oklo’s (OKLO) stock&nbsp;gained 0.7% in pre-market trade&nbsp;on Wednesday, reversing an earlier 3%&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oklo-stock-slips-after-sam-altman-steps-down-as-chair/chQmNFmRbXx">drop</a> after the company announced that co-founder Sam Altman would step down as chairman.&nbsp;The news, while initially surprising to investors, may pave the way for a key energy deal with OpenAI, according to Citi analysts.In a research note cited by TheFly, Citi highlighted the leadership change as a potential catalyst for Oklo’s long-term prospects.&nbsp;While Altman’s “abrupt departure” caught investors off guard, Citi believes it could resolve any conflict of interest related to Oklo’s ongoing discussions with OpenAI about a potential energy supply agreement.&nbsp;The brokerage noted that given Altman’s dual roles at both Oklo and OpenAI, his exit could clear the path for a more strategic partnership in the future.Citi maintained its ‘Neutral’ rating on&nbsp;<a href="https://stocktwits.com/symbol/OKLO">Oklo’s stock</a>, with a $30 price target, noting that the company has been actively seeking new board members and considering the separation of the CEO and chairman roles.&nbsp;Analysts expect the initial market reaction to be negative, but they emphasized that a deal with OpenAI could alleviate these concerns, driving positive sentiment and potential stock upside.Meanwhile, H.C. Wainwright initiated coverage of Oklo with a ‘Buy’ rating and $55 price target, pointing to the company’s growing pipeline in advanced nuclear technology.&nbsp;It noted that Oklo has secured a 14 gigawatt (GW) pipeline, including a 12GW agreement with Switch, a data center developer, that extends through 2044.Oklo’s stock has gained 1.4% year-to-date and surged over 70% in the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oklo-stock-slips-after-sam-altman-steps-down-as-chair/chQmNFmRbXx">Oklo Stock Slips After Sam Altman Steps Down As Chair, But Retail Sentiment Flips To 'Bullish'</a>

Sam Altman, former co-founder and CEO of OpenAI, speaks during a panel discussion titled "The Age of AI" at the Technical University of Berlin on February 07, 2025 in Berlin, Germany. (Photo by Sean Gallup/Getty Images)

Oklo-OpenAI Energy Deal More Likely After Sam Altman Exit, Says Citi

Citi noted that given Altman’s dual roles at both Oklo and OpenAI, his departure could pave the way for a more strategic partnership in the future.

Upstart Holdings Inc (UPST) shares surged about 26% in the after-market trade on Tuesday after the company posted a surprise profit and its fourth-quarter revenue beat Wall Street’s estimates.On an adjusted basis, the company posted earnings of $0.26 per share for the three months ended Dec. 31, compared with average analysts’ estimate of a loss of $0.15 per share.According to Koyfin data, the company reported quarterly revenue of $218.96 million, compared with the average analysts’ estimate of $181.92 million.Its net loss narrowed to $2.8 million, compared with $42.4 million in the same period last year.Upstart’s total loans jumped to 245,663 from 129,664 in the year-ago quarter, while its transaction volumes rose 66% to $2.1 billion.Its revenue from fees rose to $199.28 million from $152.86 million last year.The company expects to post $1 billion in revenue in 2025, which, if it meets its projections, will be a record annual revenue for the AI lending platform.Upstart also forecast a net interest income (NII) of about $80 million in 2025 and said it expects to at least break even this year. The company last posted a net profit in 2021.“In Q4 of 2024, our business grew dramatically across all product categories, delivered Adjusted EBITDA at levels not seen since the first quarter of 2022, and came within a whisker of returning to GAAP profitability,” CEO Dave Girouard said. &nbsp;Retail sentiment on Stocktwits moved higher in the ‘extremely bullish’ (96/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:803/184;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/UPST_Feb_12_d313e05882.JPG" alt="UPST’s Sentiment Meter and Message Volume as of 01:34 a.m. ET on Feb. 12, 2025 | Source: Stocktwits" width="803" height="184"><figcaption>UPST’s Sentiment Meter and Message Volume as of 01:34 a.m. ET on Feb. 12, 2025 | Source: Stocktwits</figcaption></figure>Users speculated if the stock could hit $350 soon, a level it last touched in 2021.<stembedurl>https://stocktwits.com/Koapark/message/603873161</stembedurl><stembedurl>https://stocktwits.com/drabon74/message/603874169</stembedurl>Over the past year, <a href="https://stocktwits.com/symbol/UPST">Upstart stock</a> has nearly doubled.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/energy-transfer-stock-falls-after-market-on-q4-revenue-miss-retail-shrugs-it-off/ch5aJ3ERub">Energy Transfer Stock Falls After-market On Q4 Revenue Miss: Retail Shrugs It Off</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Upstart Holdings logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Upstart Holdings Stock Soars Aftermarket After Surprise Q4 Profit: Retail’s Exuberant

On an adjusted basis, the company posted earnings of $0.26 per share for the three months ended Dec. 31, compared with average analysts’ estimate of a loss of $0.15 per share.

Shares of Cassava Sciences, Inc. (SAVA), a small-cap biotech firm, rose more than 5% on Tuesday after the company’s CEO, Rick Barry, provided an update on its Alzheimer’s drug trial via a regulatory 8-K filing.Barry announced that the ReTHINK Phase 3 clinical trial recently completed its final patient visit, marking a significant milestone in the development of Simufilam, a drug targeting a unique protein misfolding pathway associated with Alzheimer’s disease.Unlike traditional therapies that focus on amyloid plaques, Simufilam aims to correct the shape of the protein Filamin A, potentially addressing various Alzheimer’s disease processes.The ReTHINK trial enrolled 804 patients across 77 sites in the U.S., Puerto Rico, Canada, and Australia, with participants randomized between placebo and simufilam (100 mg twice daily). Approximately 70% of patients entered the study with mild Alzheimer’s, while the remaining 30% had moderate Alzheimer’s.Barry stated, “We expect to announce top-line results of the ReTHINK trial before year-end.” He mentioned that the proposed Statistical Analysis Plan was submitted to the FDA in July and is currently under review.Despite the positive news, retail sentiment on Stocktwits shifted from ‘bullish’ to ‘neutral’ after the update as of 1:00 pm ET. Cassava stock was the top trending ticker at 12:30 pm ET on Tuesday.<stembedurl>https://stocktwits.com/Tiffiny/message/588297923</stembedurl><stembedurl>https://stocktwits.com/Donniechen12345/message/588323050</stembedurl>The company had recently reached a $40 million settlement with the U.S. Securities and Exchange Commission (SEC) related to misleading claims about its Alzheimer’s drug trials, which had drawn considerable attention from retail investors.Following the CEO’s update, H.C. Wainwright upgraded Cassava Sciences to ‘Buy’ from ‘Neutral’, raising its price target to $116.The analyst believes the settlement has mitigated long-term challenges for the stock and anticipates a positive catalyst from the upcoming topline readout from the ReTHINK trial.Year-to-date, SAVA stock has climbed over 18%.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/ww-stock-rises-on-compounded-glp1-drug-offering/cJchFDeREX">WeightWatchers Stock Rallies After Adding Compounded Semaglutide To Offerings Amid GLP-1 Shortages: Retail Stays Cautious</a> &nbsp;

Cassava's simufilam aims to correct the shape of the protein Filamin A, potentially addressing various Alzheimer’s disease processes. 

Cassava Sciences Stock Jumps After CEO’s Update On Alzheimer’s Drug Trial: Retail Sentiment Wavers

The ReTHINK trial enrolled 804 patients across 77 sites in the U.S., Puerto Rico, Canada, and Australia, with participants randomized between placebo and simufilam (100 mg twice daily)

ULTY
YieldMax Ultra Option Income Strategy ETF

Feed

News

Sentiment

Fundamentals

Info

Latest ULTY News

ULTYYieldMax Ultra Option Income Strategy ETF